Circulating type I NKT cell deficiency leads to decreased proliferation and IFN-γ production by type I NKT cells, consequently skewing immune response to a pro-tumor Th2 cytokine profile (73, 74, 76–78, 80, 163, 164). The gene discussed is IFNG; the disease is neoplasm.